In the analysis of gastric cancer patients with different HER2 statuses, the ORRs were 35.7% for IHC 2+/FISH−, 20% for IHC 2+/FISH+, and 13.6% for IHC 3+. The gene discussed is ERBB2; the disease is gastric cancer.